1. Home
  2. NRXS vs CMBM Comparison

NRXS vs CMBM Comparison

Compare NRXS & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXS
  • CMBM
  • Stock Information
  • Founded
  • NRXS 2011
  • CMBM 2011
  • Country
  • NRXS United States
  • CMBM United States
  • Employees
  • NRXS N/A
  • CMBM N/A
  • Industry
  • NRXS
  • CMBM Radio And Television Broadcasting And Communications Equipment
  • Sector
  • NRXS
  • CMBM Technology
  • Exchange
  • NRXS Nasdaq
  • CMBM Nasdaq
  • Market Cap
  • NRXS 12.5M
  • CMBM 11.2M
  • IPO Year
  • NRXS 2023
  • CMBM 2019
  • Fundamental
  • Price
  • NRXS $2.34
  • CMBM $0.40
  • Analyst Decision
  • NRXS
  • CMBM Strong Buy
  • Analyst Count
  • NRXS 0
  • CMBM 2
  • Target Price
  • NRXS N/A
  • CMBM $5.50
  • AVG Volume (30 Days)
  • NRXS 36.9K
  • CMBM 390.5K
  • Earning Date
  • NRXS 05-21-2025
  • CMBM 05-08-2025
  • Dividend Yield
  • NRXS N/A
  • CMBM N/A
  • EPS Growth
  • NRXS N/A
  • CMBM N/A
  • EPS
  • NRXS N/A
  • CMBM N/A
  • Revenue
  • NRXS $2,685,925.00
  • CMBM $172,215,000.00
  • Revenue This Year
  • NRXS $138,883.78
  • CMBM N/A
  • Revenue Next Year
  • NRXS $118.59
  • CMBM $17.13
  • P/E Ratio
  • NRXS N/A
  • CMBM N/A
  • Revenue Growth
  • NRXS 9.18
  • CMBM N/A
  • 52 Week Low
  • NRXS $1.33
  • CMBM $0.23
  • 52 Week High
  • NRXS $3.78
  • CMBM $4.43
  • Technical
  • Relative Strength Index (RSI)
  • NRXS 65.87
  • CMBM 39.30
  • Support Level
  • NRXS $1.33
  • CMBM $0.36
  • Resistance Level
  • NRXS $2.09
  • CMBM $0.41
  • Average True Range (ATR)
  • NRXS 0.36
  • CMBM 0.05
  • MACD
  • NRXS 0.06
  • CMBM 0.02
  • Stochastic Oscillator
  • NRXS 90.95
  • CMBM 75.83

About NRXS Neuraxis Inc.

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

About CMBM Cambium Networks Corporation

Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.

Share on Social Networks: